Paroxysmal Supraventricular Tachycardia (PSVT)
Symptoms, Doctors, Treatments, Advances & More

Paroxysmal Supraventricular Tachycardia (PSVT) Overview

Save information for later
Sign Up

Learn About Paroxysmal Supraventricular Tachycardia (PSVT)

Condition 101 content is not available at this time, but we are continually updating the site. Please check back.

However, there may be experts who have treated this or similar conditions in our Find a Doctor section and research may be available in our Latest Advances section.

Who are the top Paroxysmal Supraventricular Tachycardia (PSVT) Local Doctors?
Elite in Paroxysmal Supraventricular Tachycardia (PSVT)
Elite in Paroxysmal Supraventricular Tachycardia (PSVT)

Duke Cardiology Clinic - Clinic 2F/2G

40 Duke Medicine Cir, 
Durham, NC 
Experience:
18+ years
Languages Spoken:
English
Offers Telehealth

I am excited about electrophysiology because it gives me the opportunity to improve patients' quality of life and allows patients to live longer in many cases. I ultimately went to medical school because of a passion for helping people, lifelong learning, and establishing meaningful relationships with my patients. I strongly believe in patient engagement and patient-centered decision making. Therefore, I believe that it is important to spend time educating patients and discussing all available treatment options. I encourage patients and their family members to ask questions so that I can help them understand their health. I offer medical therapy and catheter ablation therapy to patients with atrial fibrillation, atrial flutter, supraventricular tachycardia, and premature ventricular contractions (PVCs), and ventricular tachycardia. I also place transvenous pacemakers and defibrillators (ICDs), cardiac resynchronization therapy (CRT) devices, leadless pacemakers, and subcutaneous defibrillators. I also perform lead extractions. I have two children, and I enjoy cooking, as well as playing golf, tennis, and skiing. Dr. Pokorney is rated as an Elite provider by MediFind in the treatment of Paroxysmal Supraventricular Tachycardia (PSVT). He is also highly rated in 17 other conditions, according to our data. His clinical expertise encompasses Paroxysmal Supraventricular Tachycardia (PSVT), Atrial Fibrillation, Arrhythmias, Cardiac Ablation, and Pacemaker Implantation. Dr. Pokorney is board certified in American Board Of Internal Med, Cardiovascular Disease and American Board Of Internal Med, Clinical Cardiac Electrophysio.

Elite in Paroxysmal Supraventricular Tachycardia (PSVT)
Cardiac Electrophysiology
Elite in Paroxysmal Supraventricular Tachycardia (PSVT)
Cardiac Electrophysiology

Montefiore Medical Center

111 East 210th Street, 
Bronx, NY 
Languages Spoken:
English
Offers Telehealth

Andrea Natale is a Cardiac Electrophysiologist practicing medicine in Bronx, New York. Dr. Natale is rated as an Elite provider by MediFind in the treatment of Paroxysmal Supraventricular Tachycardia (PSVT). He is also highly rated in 32 other conditions, according to our data. His clinical expertise encompasses Atrial Fibrillation, Arrhythmias, Ventricular Tachycardia, Cardiac Ablation, and Pacemaker Implantation.

 
 
 
 
Learn about our expert tiers
Learn More
Elite in Paroxysmal Supraventricular Tachycardia (PSVT)
Elite in Paroxysmal Supraventricular Tachycardia (PSVT)

Brigham And Women's Hospital, Heart And Vascular Center

70 Francis Street, Carl J. And Ruth Shapiro Cardiovascular Center, 
Boston, MA 
Languages Spoken:
English
Offers Telehealth

Dr. Usha B. Tedrow is director of the Clinical Cardiac Electrophysiology Program at Brigham and Women’s Hospital’s (BWH) Heart Rhythm Program. A cardiovascular medicine specialist, she is also an assistant professor of medicine at Harvard Medical School (HMS).Dr. Tedrow received her medical degree from HMS. She completed an internal medicine residency and a cardiology fellowship at Massachusetts General Hospital. In addition, she completed a cardiac electrophysiology fellowship at BWH. Dr. Tedrow is board certified in internal medicine, cardiovascular disease and cardiac electrophysiology.Her clinical interests include atrial fibrillation, cardiac resynchronization and ventricular tachycardia. She is currently researching left ventricular mapping and pacing data to analyze novel ablation treatments for structural heart disease. In addition, Dr. Tedrow serves on the editorial board of Circulation: Arrhythmia and Electrophysiology, has authored over 120 peer-reviewed publications and has received research funding from the Heart Rhythm Society. Dr. Tedrow is rated as an Elite provider by MediFind in the treatment of Paroxysmal Supraventricular Tachycardia (PSVT). She is also highly rated in 25 other conditions, according to our data. Her clinical expertise encompasses Ventricular Tachycardia, Arrhythmias, Paroxysmal Supraventricular Tachycardia (PSVT), Cardiac Ablation, and Pacemaker Implantation. Dr. Tedrow is board certified in Clinical Cardiac Electrophysiology.

What are the latest Paroxysmal Supraventricular Tachycardia (PSVT) Clinical Trials?
Saline Enhanced Radiofrequency (SERF) Needle Ablation for Refractory VT

Summary: The Thermedical Ablation System and Durablate catheter is indicated for use in patients with recurrent, sustained, monomorphic ventricular tachycardia (SMVT) refractory to drug therapy and conventional (approved) catheter ablation. Subjects with recurrent, SMVT refractory to drug therapy and conventional catheter ablation who are not eligible for, or will not likely benefit from repeat endocardial...

Match to trials
Find the right clinical trials for you in under a minute
Get started
The NODE-202 Study Multi-Center, Multi-National, Open-Label, Efficacy and Safety Study of Etripamil Nasal Spray in Pediatric Patients With Paroxysmal Supraventricular Tachycardia

Summary: NODE-202 is a Phase 2, multicenter, multinational, single dose, open-label, 2-part, sequential design study in pediatric patients with an established diagnosis of paroxysmal supraventricular tachycardia (PSVT) presenting with a symptomatic episode of PSVT. In Part 1, at least 30 patients aged 12 to \<18 years will be enrolled and treated with etripamil nasal spray (NS). Efficacy, safety, tolerabil...